humanized glp-1 receptor knock-in mouse Chronic treatment with glucagon-like peptide-1 and glucagon co- agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity Generating a knock-in mouse model

DAlessio et al

This ongoing medical supervision is a key component of our GLP-1 weight loss program

What are GLP-1 medications and how do they work

GLP-1 medications are recommended in the ADA Standards of Care for those with cardiovascular disease, heart failure, and/or kidney disease to reduce the risk of adverse events due to these conditions

Giving yourself an injection can be daunting, but knowing more about the injection sites is crucial for success

Based on the PIONEER programme, oral semaglutide has been licensed for people with T2D and the 14 mg dose, leads to HbA1c improvement up to 1.4% and WL up to 4.4 kg [20]